RJA
HHS icon

Raymond James & Associates’s Harte-Hanks HHS Stock Holding History

Raymond James & Associates’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,000
Closed -$19K – 3514
2017
Q4 		$19K Hold
2,000
– – ﹤0.01% 3344
2017
Q3 		$21K Buy
+2,000
New +$18.4K ﹤0.01% 3311

Other funds holding HHS

FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return

Raymond James & Associates's HHS Position: Q1 2018 in Review

Raymond James & Associates sold out of Harte-Hanks (HHS) in Q1 2018, closing a stake of 2,000 shares — an estimated $19K sold.

Raymond James & Associates first reported a position in HHS in Q3 2017 and held it in 2 quarters. The position peaked at $21K in Q3 2017. 28 funds tracked by Wall St. Rank hold HHS as of Q1 2018.

  • Raymond James & Associates reported no remaining Harte-Hanks position as of Q1 2018 after selling out during the quarter.
  • Raymond James & Associates sold 2,000 Harte-Hanks shares in Q1 2018, an estimated $19K.
  • Raymond James & Associates first reported a position in Harte-Hanks in Q3 2017 and held it in 2 quarters.
  • Raymond James & Associates's Harte-Hanks position peaked at $21K in Q3 2017.
  • 28 funds tracked by Wall St. Rank held Harte-Hanks as of Q1 2018.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.